key: cord-0777779-2pib7ryu
authors: Shenavandeh, Saeedeh; Sefidbakht, Sepideh; Iranpour, Pooya; Teimouri, Arash; Hooshmandi, Sedighe; Hooshmandi, Etrat; Athari, Mohammadjavad
title: COVID-19 and granulomatosis with polyangiitis (GPA): a diagnostic challenge
date: 2020-06-17
journal: Rheumatology (Oxford)
DOI: 10.1093/rheumatology/keaa326
sha: b14f3d24b76e33f1192568a3bff177e89a6bc828
doc_id: 777779
cord_uid: 2pib7ryu

nan

DEAR EDITOR, In December 2019, a spreading outbreak of pneumonia associated with a novel coronavirus was reported in Wuhan, China, and soon was defined as a Public Health Emergency of International Concern (PHEIC) [1] . Accurate, prompt diagnosis is crucial to prevent further spread of the infection and improve clinical prognosis. This is usually suggested by clinical symptoms, especially when accompanied by a history of contact. RT-PCR test and chest CT scan are the two main diagnostic tools for the evaluation of patients who are clinically suspected to have COVID-19. In many cases, the clinician can often make a confident diagnosis based on clinical and/or imaging findings. The presence of peripheral bilateral ground-glass opacities (GGOs) with or without consolidations or visible intralobular lines is regarded as typical for COVID-19 pneumonia, especially in the setting of a high pretest probability [2] . However, when COVID-19 is superimposed on a prior lung pathology, then the imaging findings may overlap, making the diagnosis challenging. Fig 1 demonstrates axial chest CT images of a case of granulomatosis with polyangiitis (GPA) presenting during the COVID-19 outbreak. The patient was a 35-yearold man, with cavitary lung lesions, scleritis and sinusitis since 6 years ago. His disease was relatively controlled on rituximab 500 mg IV every 9 months, azathioprine 50 mg and prednisolone 7.5 mg per day with normal lung exam in his last visit one month before the admission. On 12 March 2020, he was admitted with complaints of cough, fever and dyspnoea. CT scan revealed multiple new left-sided peripheral patches of GGO in addition to the pre-existing right-side cavitary lesion. Because this finding could be a feature of either early COVID-19 pneumonia or a presentation of the GPA, the patient was admitted to an isolation ward and RT-PCR was done using a nasopharyngeal sample. The RT-PCR result came back positive for COVID-19. He received IV cefepime, azithromycin and hydroxychloroquine and was discharged after 4 days in good health condition with a recommendation of 14 days' home isolation. Follow-up visits at two and four weeks after discharge revealed significant clinical improvement with two consecutive negative RT-PCR results.

Clinical manifestations of patients infected with Severe acute respiratory syndrome (SARS) CoV-2 are varied. Fever, cough and expectoration are the most common symptoms [3] . Alveolar and interstitial changes, including GGO, consolidation, septal thickening and reticulations have all been described on high-resolution CT [1] [2] [3] . These radiologic features are, however, nonspecific and can be seen in many other lung conditions including organizing pneumonia, other viral pneumonia such as influenza virus pneumonia, and also rheumatologic diseases including lupus pneumonitis and GPA.

GPA is a condition characterized by a necrotizing granulomatous vasculitis with the ability to affect different organs. Lung involvement has been reported in many cases, hence, the CT scan commonly performed in GPA. Major pulmonary CT scan findings are GGOs, pulmonary nodules, masses and consolidations [4] . Lung haemorrhage, which is seen in the active phase of the disease, may present as ground-glass opacity and consolidation in CT studies. Moreover, lung infarctions

Rheumatology key message . Accurate diagnosis of COVID infection is especially important in those with comorbid lung conditions such as GPA. due to small vessel vasculitis can also appear as consolidation [5] . While pulmonary nodules and mass lesions are not typical for COVID, GGOs with or without consolidations are highly suggestive of COVID-19 pneumonia [2] . As GPA and COVID-19 pneumonia share clinical and radiological features, discrimination based on imaging could be cumbersome. Prompt diagnosis and appropriate clinical management of COVID-19 superinfection in such cases are essential to prevent further morbidity and mortality [6] . This was the case in our patient. In such conditions, the specificity of a chest CT scan in proposing a correct diagnosis may be reduced; therefore, meticulous attention to the recent clinical presentation and also past medical records, together with the application of confirmatory laboratory tests such as RT-PCR can be problem-solving.

Coronavirus disease 2019 (COVID-19): a perspective from China

Radiological Society of North America Expert Consensus statement on reporting chest CT findings related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA

Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city

Common and uncommon manifestations of Wegener granulomatosis at chest CT: radiologic-pathologic correlation

Pulmonary manifestations of Wegener granulomatosis: CT findings in 57 patients and a review of the literature

Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia

Informed consent has been obtained from the patient.Funding: No specific funding was received from any funding bodies in the public, commercial or not-forprofit sectors to carry out the work described in this manuscript.Disclosure statement: The authors have declared no conflicts of interest.